CLINICAL_TRIALS
trial_result
· 2021-09-09
Clinical Trial Update: Intranasal (NAS) Ketamine for Cancer Pain [Phase 1, Phase 2]
Summary
Phase 1/2 trial investigating intranasal ketamine for cancer-related pain has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Cancer, Pain | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-09-09